ERBB2 and breast cancer: Triple negative breast cancer composes a breast cancer type whose cells do not express receptors for the human epidermal growth factor receptor 2 (HER2) protein or the hormones progesterone and estrogen, and accounts for roughly 15% of all breast cancer [2].